Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...

Abbott (NYSE: ABT) received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy ...

A new study found that cannabis users under the age of 50 are about 6.2 times more likely to experience a heart attack than ...

Abbott Laboratories (NYSE:ABT) has caught investor attention with the FDA’s approval of an Investigational Device Exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System, a significant ...

A subgroup analysis of the FAME 3 randomized clinical trial has revealed that the relative benefit of Coronary Artery Bypass ...

John Baker, MD, cardiologist with West Tennessee Medical Group, recently performed the first procedure using the AGENT™ ...

An updated guideline has been published by the AHA, ACC, and other organizations regarding the management of acute coronary syndrome.

Coronary artery disease, a collective term for angina and heart attacks, is among the most common causes of death among women. A study published in Circulation, conducted by Tormod Rogne from Yale ...

People with HIV in Uganda do not have a higher prevalence of coronary artery disease compared to people without HIV. Among both groups, the prevalence of coronary artery disease was low compared to ...

Most people probably would not connect seasonal allergies with their hearts. Itchy, watery eyes and stuffy noses, sure—but ...